Trials / Unknown
UnknownNCT04315753
Circulating and Imaging Biomarkers to Improve Lung Cancer Management and Early Detection
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Istituto Clinico Humanitas · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
Validation of biomolecular markers in the circulation and radiomic features are the focus of this project.The aim is to assess the role of molecular and cellular biomarkers (exosomes antigens, Circulating tumor cells - CTCs, panel of mutations in circulating free DNA) and radiomic signature, as complementary to assist early detection of lung cancer by LDCT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | LDCT (Low Dose CT) | validate the role of non-invasive molecular and cellular biomarkers and combined radiomic signature, as complementary tools to assist early detection of lung cancer by LDCT using bioinformatic techniques for the integration of the results |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2023-01-01
- Completion
- 2023-01-01
- First posted
- 2020-03-20
- Last updated
- 2020-03-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04315753. Inclusion in this directory is not an endorsement.